COVID-19: Should ACE inhibitors and Angiotensin Receptor Blockers Be Withdrawn? Have They Been Demonstrated to be Directly Related to Damage to the CV or Pulmonary Systems in COVID-19 Patients?
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Keith Ferdinand
May 22, 2020
Login to view comments.
Click here to Login